Translocations of the ETS transcription factors, including ETV1, occur in half of all prostate cancers resulting in aberrant ETS transcription factor expression which are believed to be an early, potentially initiating event, for prostate cancer [23–25]. The gene discussed is ETV1; the disease is prostate carcinoma.